EP3512547
And-PD-1 mótefni
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
14.9.2017EP published:
11.11.2020EP application number:
17772258.4
EP translation filed:
2.12.2020Grant published:
15.12.2020EPO information:
European Patent Register
Max expiry date:
13.9.2037Expiry date:
13.9.2026Next due date:
30.9.2026
Title:
ANTI-PD-1 ANTIBODIES
Timeline
Today
14.9.2017EP application
11.11.2020EP Publication
2.12.2020Translation submitted
15.12.2020Registration published
13.9.2026Expires
Owner
Name:
AbbVie Biotherapeutics Inc.Address:
1500 Seaport Boulevard, Redwood City, CA 94063, US
Inventor
Name:
AFAR, Daniel E. H.Address:
Los Altos Hills California 94022, US
Name:
HARDING, Fiona A.Address:
Mountain View California 94041, US
Name:
SAMAYOA, JosueAddress:
San Mateo California 94402, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201662394314 PDate:
14.9.2016Country:
US
Classification
Categories:
C07K 16/28, A61K 39/395, A61P 35/00, A61P 37/04
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 11.8.2021
Expires: 13.9.2022
Payer: Örn Þór slf.
Number: 6
Paid: 16.8.2022
Expires: 13.9.2023
Payer: Árnason Faktor ehf.
Number: 7
Paid: 30.6.2023
Expires: 13.9.2024
Payer: Árnason Faktor ehf.
Number: 8
Paid: 15.8.2024
Expires: 13.9.2025
Payer: Árnason Faktor ehf.
Number: 9
Paid: 10.9.2025
Expires: 13.9.2026
Payer: Árnason Faktor ehf.